| 发明名称 |
BIOMARKERS FOR PREDICTING SUSTAINED RESPONSE TO HCV TREATMENT |
| 摘要 |
The present invention is based on the discovery that in patients infected with Genotype 1 of the Hepatitis C virus (HCV-1) or Genotype 4 HCV (HCV-4) that undergo Triple Therapy treatment, certain biomarkers can be predictive of a patient achieving sustained virologic response |
| 申请公布号 |
US2011312513(A1) |
申请公布日期 |
2011.12.22 |
| 申请号 |
US20100958662 |
申请日期 |
2010.12.02 |
| 申请人 |
CHIU SHU-HUI;ZHU YONGHONG;ROCHE MOLECULAR SYSTEMS, INC. |
发明人 |
CHIU SHU-HUI;ZHU YONGHONG |
| 分类号 |
C12Q1/70;G06F19/00 |
主分类号 |
C12Q1/70 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
